Precision Medicine World Conference – COVID (PMWC)

  • -

21st Century Precision Medicine in the Age of COVID-19

PMWC COVID: Jan 25-27, 2021 | 21st Century Precision Medicine in the Age of COVID-19

Day 2 (January 26): COVID-19 Emerging Therapeutics, Vaccine Development & Diagnostics 

Transcriptional Diversity and Its Impact on COVID-19 Outcome

SARS-CoV-2 course of infection and disease severity is not fully understood at an individual patient level which is reflected in the observed clinical heterogeneity to viral infection. Tissue profiling offers an opportunity to shed light on this complexity heterogeneity which also translates into varied COVID-19 pathology and may also impact treatment response. This session includes clinical leaders discussing patterns of viral dissemination and immune response throughout the body and efforts to optimize COVID-19 treatment approaches based on transcriptional and proteomic findings.

Session Chair

Sarah Warren, PhD, Director of Advanced Applications, NanoString Technologies


Carl June, MD, PhD, Parker Institute for Cancer Immunotherapy, University of Pennsylvania
Robert Schwartz, MD, PhD, Weill Cornell Medicine
Omer Bayraktar, PhD, Wellcome Sanger Institute, UK
Mathai Mammen, MD, PhD, Johnson & Johnson